Thalidomide for patients with thalassemia intermedia: a retrospective multicenter clinical study
Conclusion: Thalidomide had significant therapeutic effects on patients with TI, and the response was sustained with acceptable short-term and long-term adverse reactions. While these preliminary results support the potential long-term efficacy and safety of thalidomide as a therapeutic agent for TI, several issues need to be addressed before its application in the clinic.
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Authors: Kun Yang, Yi Wu, Yali Zhou, Tianhong Zhou, Li Wang, Zhili Geng, Xiaolin Yin Source Type: research
More News: Blood Transusion | Brain | Hematology | Infectious Diseases | Laboratory Medicine | Neurology | Study